The Trial Script voucher program for Rheumatrex Dose Pack (methotrexate sodium tablets) has been extended to August 2005. Rheumatrex, manufactured by STADA Pharmaceuticals, Inc, is a once-weekly disease-modifying antirheumatic drug for rheumatoid arthritis.
In the voucher program, patients receive a free 1-month trial supply of Rheumatrex in any weekly dosage available (5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg). Physicians affix the voucher to the back of the prescription form. The patients activate the voucher by calling a toll-free number. Transactions are electronically processed through drug utilization programs, which may detect potential drug interactions.
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.
Clinical features with downloadable PDFs